Study: Med device excise tax cost medtech R&D $34m

The 2.3% medical device excise tax that was imposed as part of the Affordable Care Act has cost the medical device industry approximately $34 million in R&D expenditures and $568 million across sales revenue, gross margins and earnings since its implementation, according to a new study.